Editorial Disclosure: GLP-1 Editorial is an editorial publication operated by Ranika Editorial Group LLC. We do not provide medical care, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Our rankings are based on our published v3.0 transparency rubric, publicly available provider information, cited sources, and periodic review updates. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page and at /affiliate-disclosure.html.
Last reviewed: May 31, 2026
Next scheduled review: June 30, 2026
Reviewed by: Dr. Sam Saberian, Lead Medical Researcher
Edited by: Julliana Edwards, Editor
Methodology: GLP-1 Editorial v3.0 rubric
Compounded GLP-1 provider

Found

Semaglutide + Tirzepatide
Found compounded semaglutide + tirzepatide injection vial — editorial illustration
Provider Review · 74/100 · Updated 2026-05-08

Found Review

Mixed model — branded GLP-1s plus compounded options. Zero pillars met against our v3.0 rubric due to limited public disclosure on pharmacy and outcomes.

#8 of 1074/100$199/mo
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11

Overview

Mixed model — branded GLP-1s plus compounded options. Zero pillars met against our v3.0 rubric due to limited public disclosure on pharmacy and outcomes.

Found at a glance

Editorial rank
#8 of 10
Score
74/100 · 3.7/5 stars
Pillars met
0 of 6
Pricing
$199/mo
Pharmacy model
Mixed brand + compounded
Clinical model
Compounded + branded mix

Six-pillar scoring

Found meets 0 of 6 v3.0 transparency pillars. No pillars met means cohort outcomes, AE disclosure, and pharmacy traceability documentation are limited per our review.

Pricing

$199/mo. Verify final pricing directly with the provider before purchasing — prices may change.

Trade-offs to know

How to evaluate Found

If you're considering Found, verify directly: (1) named Medical Director and state licensure, (2) the dispensing pharmacy on every shipment label, (3) whether per-batch CoAs (USP <71>, USP <85>, HPLC potency) are available on request, (4) the full out-of-pocket monthly cost across the titration schedule, (5) the FDA-approval status of any medication you're prescribed.

Visit Found →

Important medical and regulatory disclosure: Compounded semaglutide and compounded tirzepatide are not FDA-approved. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Editorial does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.